Act Capital Management, LLC Medicenna Therapeutics Corp. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Medicenna Therapeutics Corp. stock. As of the latest transaction made, Act Capital Management, LLC holds 149,070 shares of MDNA stock, worth $46,211. This represents 0.17% of its overall portfolio holdings.
Number of Shares
149,070
Previous 149,070
-0.0%
Holding current value
$46,211
Previous $173,000
28.32%
% of portfolio
0.17%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding MDNA
# of Institutions
3Shares Held
863KCall Options Held
0Put Options Held
0About Medicenna Therapeutics Corp.
- Ticker MDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,637,504
- Market Cap $21.6M
- Description
- Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...